AtlasKam padedameMūsų mokslasProduktaiRezultatai
PrisijungtiKlaustiSekvenuokite savo genomą↗
Požymis
Weight loss
Reduction of total body weight.
Santrauka
- Taip pat vadinama
- Loss of weight
- Kūno sistema
- Growth abnormality
AtlasKam padedameMūsų mokslasProduktaiRezultatai
PrisijungtiKlaustiSekvenuokite savo genomą↗
Ši puslapis kaip duomenys
Norėdami perskaityti jį kaip JSON, pridėkite .json prie puslapio adreso arba nurodykite application/json.
library(jsonlite)
url <- "https://dantelabs.com/traits/weight-loss.json"
page <- fromJSON(url)
page$trait$nameWeight lossHP:0001824
AtlasKam padedameMūsų mokslasProduktaiRezultatai
PrisijungtiKlaustiSekvenuokite savo genomą↗
Vienu tyrimu sužinokite genus, susijusius su Weight loss, ir kitą jūsų genomo dalį.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test353 genų susiję su Weight loss
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia Weight loss. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| ABCB7ATP binding cassette subfamily B member 7 | Visada | 1 ligoje |
| CTNScystinosin, lysosomal cystine transporter | Visada | 1 ligoje |
| FLNAfilamin A | Visada | 1 ligoje |
| KCNJ18potassium inwardly rectifying channel subfamily J member 18 | Visada | 2 ligose |
| KLF1KLF transcription factor 1 | Visada | 1 ligoje |
| POLGDNA polymerase gamma, catalytic subunit | Visada | 4 ligose |
| PTCRApre T cell antigen receptor alpha | Visada | 1 ligoje |
| TYMPthymidine phosphorylase | Visada | 2 ligose |
| ABCC8ATP binding cassette subfamily C member 8 | Labai dažnai (80–99%) | 1 ligoje |
| ABCD3ATP binding cassette subfamily D member 3 | Labai dažnai (80–99%) | 1 ligoje |
| ATMATM serine/threonine kinase | Labai dažnai (80–99%) | 2 ligose |
| ATP7BATPase copper transporting beta | Labai dažnai (80–99%) | 1 ligoje |
| BANK1B cell scaffold protein with ankyrin repeats 1 | Labai dažnai (80–99%) | 1 ligoje |
| BCL10BCL10 immune signaling adaptor | Labai dažnai (80–99%) | 1 ligoje |
| BCL2BCL2 apoptosis regulator | Labai dažnai (80–99%) | 1 ligoje |
| BCL6BCL6 transcription repressor | Labai dažnai (80–99%) | 1 ligoje |
| BIRC3baculoviral IAP repeat containing 3 | Labai dažnai (80–99%) | 1 ligoje |
| BLKBLK proto-oncogene, Src family tyrosine kinase | Labai dažnai (80–99%) | 1 ligoje |
| BMPR1Abone morphogenetic protein receptor type 1A | Labai dažnai (80–99%) | 1 ligoje |
| BRCA1BRCA1 DNA repair associated | Labai dažnai (80–99%) | 2 ligose |
| BRCA2BRCA2 DNA repair associated | Labai dažnai (80–99%) | 4 ligose |
| C4Acomplement C4A (Chido/Rodgers blood group) | Labai dažnai (80–99%) | 2 ligose |
| C4Bcomplement C4B (Chido/Rodgers blood group) | Labai dažnai (80–99%) | 1 ligoje |
| CDKN2Acyclin dependent kinase inhibitor 2A | Labai dažnai (80–99%) | 2 ligose |
| CHEK2checkpoint kinase 2 | Labai dažnai (80–99%) | 2 ligose |
| CR2complement C3d receptor 2 | Labai dažnai (80–99%) | 1 ligoje |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Labai dažnai (80–99%) | 3 ligose |
| DCTN1dynactin subunit 1 | Labai dažnai (80–99%) | 3 ligose |
| DNASE1deoxyribonuclease 1 | Labai dažnai (80–99%) | 1 ligoje |
| EPCAMepithelial cell adhesion molecule | Labai dažnai (80–99%) | 2 ligose |
| ETS1ETS proto-oncogene 1, transcription factor | Labai dažnai (80–99%) | 1 ligoje |
| FCGR2BFc gamma receptor IIb | Labai dažnai (80–99%) | 1 ligoje |
| FCGR3BFc gamma receptor IIIb | Labai dažnai (80–99%) | 1 ligoje |
| FOXP1forkhead box P1 | Labai dažnai (80–99%) | 1 ligoje |
| GCKglucokinase | Labai dažnai (80–99%) | 1 ligoje |
| GIPC1GIPC PDZ domain containing family member 1 | Labai dažnai (80–99%) | 1 ligoje |
| GJA1gap junction protein alpha 1 | Labai dažnai (80–99%) | 1 ligoje |
| GJB3gap junction protein beta 3 | Labai dažnai (80–99%) | 1 ligoje |
| GJB4gap junction protein beta 4 | Labai dažnai (80–99%) | 1 ligoje |
| HLA-Bmajor histocompatibility complex, class I, B | Labai dažnai (80–99%) | 5 ligose |
Rodyti dar 313 genų
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Labai dažnai (80–99%) | 1 ligoje |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Labai dažnai (80–99%) | 2 ligose |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Labai dažnai (80–99%) | 3 ligose |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Labai dažnai (80–99%) | 7 ligose |
| HLCSholocarboxylase synthetase | Labai dažnai (80–99%) | 1 ligoje |
| IGHimmunoglobulin heavy locus | Labai dažnai (80–99%) | 3 ligose |
| IGHG1immunoglobulin heavy constant gamma 1 (G1m marker) | Labai dažnai (80–99%) | 1 ligoje |
| IKZF1IKAROS family zinc finger 1 | Labai dažnai (80–99%) | 1 ligoje |
| IL10interleukin 10 | Labai dažnai (80–99%) | 3 ligose |
| IL12Binterleukin 12B | Labai dažnai (80–99%) | 1 ligoje |
| INSinsulin | Labai dažnai (80–99%) | 1 ligoje |
| IRAK1interleukin 1 receptor associated kinase 1 | Labai dažnai (80–99%) | 1 ligoje |
| IRF5interferon regulatory factor 5 | Labai dažnai (80–99%) | 1 ligoje |
| ITGAMintegrin subunit alpha M | Labai dažnai (80–99%) | 1 ligoje |
| JAK2Janus kinase 2 | Labai dažnai (80–99%) | 3 ligose |
| JAZF1JAZF zinc finger 1 | Labai dažnai (80–99%) | 1 ligoje |
| KCNJ11potassium inwardly rectifying channel subfamily J member 11 | Labai dažnai (80–99%) | 1 ligoje |
| KDSR3-ketodihydrosphingosine reductase | Labai dažnai (80–99%) | 1 ligoje |
| KIAA0319LKIAA0319 like | Labai dažnai (80–99%) | 1 ligoje |
| KRASKRas proto-oncogene, GTPase | Labai dažnai (80–99%) | 2 ligose |
| KRT1keratin 1 | Labai dažnai (80–99%) | 1 ligoje |
| KRT10keratin 10 | Labai dažnai (80–99%) | 1 ligoje |
| LMNAlamin A/C | Labai dažnai (80–99%) | 1 ligoje |
| LPIN2lipin 2 | Labai dažnai (80–99%) | 1 ligoje |
| LRP12LDL receptor related protein 12 | Labai dažnai (80–99%) | 3 ligose |
| MALT1MALT1 paracaspase | Labai dažnai (80–99%) | 1 ligoje |
| MECP2methyl-CpG binding protein 2 | Labai dažnai (80–99%) | 1 ligoje |
| MLH1mutL homolog 1 | Labai dažnai (80–99%) | 1 ligoje |
| MLXMAX dimerization protein MLX | Labai dažnai (80–99%) | 1 ligoje |
| MSH2mutS homolog 2 | Labai dažnai (80–99%) | 1 ligoje |
| MSH6mutS homolog 6 | Labai dažnai (80–99%) | 1 ligoje |
| MUTYHmutY DNA glycosylase | Labai dažnai (80–99%) | 1 ligoje |
| NOTCH2NLCnotch 2 N-terminal like C | Labai dažnai (80–99%) | 1 ligoje |
| NPATnuclear protein, coactivator of histone transcription | Labai dažnai (80–99%) | 1 ligoje |
| NUTM2B-AS1NUTM2B antisense RNA 1 | Labai dažnai (80–99%) | 1 ligoje |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Labai dažnai (80–99%) | 1 ligoje |
| PALB2partner and localizer of BRCA2 | Labai dažnai (80–99%) | 2 ligose |
| PALLDpalladin, cytoskeletal associated protein | Labai dažnai (80–99%) | 1 ligoje |
| PDCD1programmed cell death 1 | Labai dažnai (80–99%) | 1 ligoje |
| PDX1pancreatic and duodenal homeobox 1 | Labai dažnai (80–99%) | 1 ligoje |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Labai dažnai (80–99%) | 1 ligoje |
| PMS1PMS1 homolog 1, mismatch repair system component | Labai dažnai (80–99%) | 1 ligoje |
| PMS2PMS1 homolog 2, mismatch repair system component | Labai dažnai (80–99%) | 1 ligoje |
| POLD1DNA polymerase delta 1, catalytic subunit | Labai dažnai (80–99%) | 1 ligoje |
| POLEDNA polymerase epsilon, catalytic subunit | Labai dažnai (80–99%) | 1 ligoje |
| PRTN3proteinase 3 | Labai dažnai (80–99%) | 1 ligoje |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Labai dažnai (80–99%) | 4 ligose |
| PXKPX domain containing serine/threonine kinase like | Labai dažnai (80–99%) | 1 ligoje |
| RABL3RAB, member of RAS oncogene family like 3 | Labai dažnai (80–99%) | 1 ligoje |
| RILPL1Rab interacting lysosomal protein like 1 | Labai dažnai (80–99%) | 1 ligoje |
| RPS20ribosomal protein S20 | Labai dažnai (80–99%) | 1 ligoje |
| SEMA4Asemaphorin 4A | Labai dažnai (80–99%) | 1 ligoje |
| SLC5A1solute carrier family 5 member 1 | Labai dažnai (80–99%) | 1 ligoje |
| SMAD4SMAD family member 4 | Labai dažnai (80–99%) | 1 ligoje |
| SPP1secreted phosphoprotein 1 | Labai dažnai (80–99%) | 1 ligoje |
| STAT3signal transducer and activator of transcription 3 | Labai dažnai (80–99%) | 2 ligose |
| STAT4signal transducer and activator of transcription 4 | Labai dažnai (80–99%) | 3 ligose |
| TGFBR2transforming growth factor beta receptor 2 | Labai dažnai (80–99%) | 1 ligoje |
| TLR7toll like receptor 7 | Labai dažnai (80–99%) | 1 ligoje |
| TNFAIP3TNF alpha induced protein 3 | Labai dažnai (80–99%) | 1 ligoje |
| TNFSF4TNF superfamily member 4 | Labai dažnai (80–99%) | 1 ligoje |
| TNIP1TNFAIP3 interacting protein 1 | Labai dažnai (80–99%) | 1 ligoje |
| TP53tumor protein p53 | Labai dažnai (80–99%) | 3 ligose |
| TREX1three prime repair exonuclease 1 | Labai dažnai (80–99%) | 1 ligoje |
| TSHRthyroid stimulating hormone receptor | Labai dažnai (80–99%) | 2 ligose |
| UBE2L3ubiquitin conjugating enzyme E2 L3 | Labai dažnai (80–99%) | 1 ligoje |
| ZMPSTE24zinc metallopeptidase STE24 | Labai dažnai (80–99%) | 1 ligoje |
| AAASaladin WD repeat nucleoporin | Dažnai (30–79%) | 1 ligoje |
| ABCD1ATP binding cassette subfamily D member 1 | Dažnai (30–79%) | 1 ligoje |
| ACTA1actin alpha 1, skeletal muscle | Dažnai (30–79%) | 1 ligoje |
| AK2adenylate kinase 2 | Dažnai (30–79%) | 1 ligoje |
| ALKALK receptor tyrosine kinase | Dažnai (30–79%) | 1 ligoje |
| ANGangiogenin | Dažnai (30–79%) | 1 ligoje |
| ANO1anoctamin 1 | Dažnai (30–79%) | 1 ligoje |
| ANXA11annexin A11 | Dažnai (30–79%) | 1 ligoje |
| ASXL1ASXL transcriptional regulator 1 | Dažnai (30–79%) | 2 ligose |
| ATP7AATPase copper transporting alpha | Dažnai (30–79%) | 1 ligoje |
| ATRXATRX chromatin remodeler | Dažnai (30–79%) | 1 ligoje |
| ATXN2ataxin 2 | Dažnai (30–79%) | 1 ligoje |
| AVParginine vasopressin | Dažnai (30–79%) | 1 ligoje |
| B2Mbeta-2-microglobulin | Dažnai (30–79%) | 1 ligoje |
| BAP1BRCA1 associated deubiquitinase 1 | Dažnai (30–79%) | 1 ligoje |
| BCORBCL6 corepressor | Dažnai (30–79%) | 1 ligoje |
| BTNL2butyrophilin like 2 | Dažnai (30–79%) | 1 ligoje |
| CACNA1Scalcium voltage-gated channel subunit alpha1 S | Dažnai (30–79%) | 2 ligose |
| CBLCbl proto-oncogene | Dažnai (30–79%) | 1 ligoje |
| CCND1cyclin D1 | Dažnai (30–79%) | 2 ligose |
| CCNFcyclin F | Dažnai (30–79%) | 1 ligoje |
| CDC73cell division cycle 73 | Dažnai (30–79%) | 1 ligoje |
| CDH23cadherin related 23 | Dažnai (30–79%) | 1 ligoje |
| CDKN1Bcyclin dependent kinase inhibitor 1B | Dažnai (30–79%) | 1 ligoje |
| CDKN2Bcyclin dependent kinase inhibitor 2B | Dažnai (30–79%) | 1 ligoje |
| CFAP410cilia and flagella associated protein 410 | Dažnai (30–79%) | 1 ligoje |
| CHCHD10coiled-coil-helix-coiled-coil-helix domain containing 10 | Dažnai (30–79%) | 1 ligoje |
| CHMP2Bcharged multivesicular body protein 2B | Dažnai (30–79%) | 1 ligoje |
| CRLF1cytokine receptor like factor 1 | Dažnai (30–79%) | 1 ligoje |
| CTNNB1catenin beta 1 | Dažnai (30–79%) | 1 ligoje |
| DAOD-amino acid oxidase | Dažnai (30–79%) | 1 ligoje |
| DLSTdihydrolipoamide S-succinyltransferase | Dažnai (30–79%) | 1 ligoje |
| DNMT3ADNA methyltransferase 3 alpha | Dažnai (30–79%) | 1 ligoje |
| ECE1endothelin converting enzyme 1 | Dažnai (30–79%) | 1 ligoje |
| EDN3endothelin 3 | Dažnai (30–79%) | 1 ligoje |
| EDNRBendothelin receptor type B | Dažnai (30–79%) | 1 ligoje |
| EHHADHenoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase | Dažnai (30–79%) | 1 ligoje |
| ELF4E74 like ETS transcription factor 4 | Dažnai (30–79%) | 1 ligoje |
| EPAS1endothelial PAS domain protein 1 | Dažnai (30–79%) | 1 ligoje |
| ERBB2erb-b2 receptor tyrosine kinase 2 | Dažnai (30–79%) | 1 ligoje |
| ERBB3erb-b2 receptor tyrosine kinase 3 | Dažnai (30–79%) | 1 ligoje |
| ERBB4erb-b2 receptor tyrosine kinase 4 | Dažnai (30–79%) | 1 ligoje |
| EWSR1EWS RNA binding protein 1 | Dažnai (30–79%) | 1 ligoje |
| FHfumarate hydratase | Dažnai (30–79%) | 1 ligoje |
| FIG4FIG4 phosphoinositide 5-phosphatase | Dažnai (30–79%) | 1 ligoje |
| FIP1L1factor interacting with PAPOLA and CPSF1 | Dažnai (30–79%) | 1 ligoje |
| FUSFUS RNA binding protein | Dažnai (30–79%) | 1 ligoje |
| GABRA3gamma-aminobutyric acid type A receptor subunit alpha3 | Dažnai (30–79%) | 1 ligoje |
| GATA2GATA binding protein 2 | Dažnai (30–79%) | 1 ligoje |
| GATA4GATA binding protein 4 | Dažnai (30–79%) | 1 ligoje |
| GATMglycine amidinotransferase | Dažnai (30–79%) | 1 ligoje |
| GDNFglial cell derived neurotrophic factor | Dažnai (30–79%) | 1 ligoje |
| GLE1GLE1 RNA export mediator | Dažnai (30–79%) | 1 ligoje |
| GLT8D1glycosyltransferase 8 domain containing 1 | Dažnai (30–79%) | 1 ligoje |
| GMPPAGDP-mannose pyrophosphorylase A | Dažnai (30–79%) | 1 ligoje |
| GPR35G protein-coupled receptor 35 | Dažnai (30–79%) | 1 ligoje |
| HACD13-hydroxyacyl-CoA dehydratase 1 | Dažnai (30–79%) | 1 ligoje |
| HACE1HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 | Dažnai (30–79%) | 1 ligoje |
| HAVCR2hepatitis A virus cellular receptor 2 | Dažnai (30–79%) | 1 ligoje |
| HLA-DQA1major histocompatibility complex, class II, DQ alpha 1 | Dažnai (30–79%) | 2 ligose |
| HNRNPA1heterogeneous nuclear ribonucleoprotein A1 | Dažnai (30–79%) | 1 ligoje |
| HTThuntingtin | Dažnai (30–79%) | 2 ligose |
| IRF2BP2interferon regulatory factor 2 binding protein 2 | Dažnai (30–79%) | 1 ligoje |
| ITGA7integrin subunit alpha 7 | Dažnai (30–79%) | 1 ligoje |
| KIF1Bkinesin family member 1B | Dažnai (30–79%) | 2 ligose |
| KITKIT proto-oncogene, receptor tyrosine kinase | Dažnai (30–79%) | 1 ligoje |
| LIG3DNA ligase 3 | Dažnai (30–79%) | 1 ligoje |
| LIN28Blin-28 RNA binding posttranscriptional regulator B | Dažnai (30–79%) | 1 ligoje |
| LMO1LIM domain only 1 | Dažnai (30–79%) | 1 ligoje |
| MAP3K20mitogen-activated protein kinase kinase kinase 20 | Dažnai (30–79%) | 1 ligoje |
| MATR3matrin 3 | Dažnai (30–79%) | 1 ligoje |
| MAXMYC associated transcriptional regulator X | Dažnai (30–79%) | 1 ligoje |
| MC2Rmelanocortin 2 receptor | Dažnai (30–79%) | 1 ligoje |
| MDH2malate dehydrogenase 2 | Dažnai (30–79%) | 1 ligoje |
| MEN1menin 1 | Dažnai (30–79%) | 1 ligoje |
| MRAPmelanocortin 2 receptor accessory protein | Dažnai (30–79%) | 1 ligoje |
| MST1macrophage stimulating 1 | Dažnai (30–79%) | 1 ligoje |
| MYCNMYCN proto-oncogene, bHLH transcription factor | Dažnai (30–79%) | 1 ligoje |
| MYL2myosin light chain 2 | Dažnai (30–79%) | 1 ligoje |
| NABP1nucleic acid binding protein 1 | Dažnai (30–79%) | 1 ligoje |
| NDUFAF6NADH:ubiquinone oxidoreductase complex assembly factor 6 | Dažnai (30–79%) | 1 ligoje |
| NEFHneurofilament heavy chain | Dažnai (30–79%) | 1 ligoje |
| NEK1NIMA related kinase 1 | Dažnai (30–79%) | 1 ligoje |
| NF1neurofibromin 1 | Dažnai (30–79%) | 1 ligoje |
| NNTnicotinamide nucleotide transhydrogenase | Dažnai (30–79%) | 1 ligoje |
| NOD2nucleotide binding oligomerization domain containing 2 | Dažnai (30–79%) | 2 ligose |
| NOS1nitric oxide synthase 1 | Dažnai (30–79%) | 1 ligoje |
| NPM1nucleophosmin 1 | Dažnai (30–79%) | 1 ligoje |
| NRTNneurturin | Dažnai (30–79%) | 1 ligoje |
| NUMA1nuclear mitotic apparatus protein 1 | Dažnai (30–79%) | 1 ligoje |
| OPTNoptineurin | Dažnai (30–79%) | 1 ligoje |
| PFN1profilin 1 | Dažnai (30–79%) | 1 ligoje |
| PHOX2Bpaired like homeobox 2B | Dažnai (30–79%) | 1 ligoje |
| PIK3R1phosphoinositide-3-kinase regulatory subunit 1 | Dažnai (30–79%) | 1 ligoje |
| PMLPML nuclear body scaffold | Dažnai (30–79%) | 1 ligoje |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Dažnai (30–79%) | 2 ligose |
| PRPHperipherin | Dažnai (30–79%) | 1 ligoje |
| RARAretinoic acid receptor alpha | Dažnai (30–79%) | 1 ligoje |
| RETret proto-oncogene | Dažnai (30–79%) | 3 ligose |
| RHBDF2rhomboid 5 homolog 2 | Dažnai (30–79%) | 1 ligoje |
| RRM2Bribonucleotide reductase regulatory TP53 inducible subunit M2B | Dažnai (30–79%) | 2 ligose |
| RUNX1RUNX family transcription factor 1 | Dažnai (30–79%) | 1 ligoje |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Dažnai (30–79%) | 3 ligose |
| SDHAF1succinate dehydrogenase complex assembly factor 1 | Dažnai (30–79%) | 1 ligoje |
| SDHAF2succinate dehydrogenase complex assembly factor 2 | Dažnai (30–79%) | 1 ligoje |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Dažnai (30–79%) | 4 ligose |
| SDHCsuccinate dehydrogenase complex subunit C | Dažnai (30–79%) | 2 ligose |
| SDHDsuccinate dehydrogenase complex subunit D | Dažnai (30–79%) | 4 ligose |
| SELENONselenoprotein N | Dažnai (30–79%) | 1 ligoje |
| SEMA3Csemaphorin 3C | Dažnai (30–79%) | 1 ligoje |
| SEMA3Dsemaphorin 3D | Dažnai (30–79%) | 1 ligoje |
| SEMA4Dsemaphorin 4D | Dažnai (30–79%) | 1 ligoje |
| SLC25A11solute carrier family 25 member 11 | Dažnai (30–79%) | 1 ligoje |
| SLC2A3solute carrier family 2 member 3 | Dažnai (30–79%) | 1 ligoje |
| SLC34A1solute carrier family 34 member 1 | Dažnai (30–79%) | 1 ligoje |
| SMOsmoothened, frizzled class receptor | Dažnai (30–79%) | 1 ligoje |
| SOD1superoxide dismutase 1 | Dažnai (30–79%) | 1 ligoje |
| SQSTM1sequestosome 1 | Dažnai (30–79%) | 1 ligoje |
| SREBF1sterol regulatory element binding transcription factor 1 | Dažnai (30–79%) | 1 ligoje |
| SRSF2serine and arginine rich splicing factor 2 | Dažnai (30–79%) | 2 ligose |
| STARsteroidogenic acute regulatory protein | Dažnai (30–79%) | 1 ligoje |
| STAT1signal transducer and activator of transcription 1 | Dažnai (30–79%) | 1 ligoje |
| STAT5Bsignal transducer and activator of transcription 5B | Dažnai (30–79%) | 1 ligoje |
| SYKspleen associated tyrosine kinase | Dažnai (30–79%) | 1 ligoje |
| TAF15TATA-box binding protein associated factor 15 | Dažnai (30–79%) | 1 ligoje |
| TARDBPTAR DNA binding protein | Dažnai (30–79%) | 1 ligoje |
| TBK1TANK binding kinase 1 | Dažnai (30–79%) | 1 ligoje |
| TBL1XR1TBL1X/Y related 1 | Dažnai (30–79%) | 1 ligoje |
| TCF4transcription factor 4 | Dažnai (30–79%) | 1 ligoje |
| TERTtelomerase reverse transcriptase | Dažnai (30–79%) | 1 ligoje |
| TET2tet methylcytosine dioxygenase 2 | Dažnai (30–79%) | 2 ligose |
| TMEM127transmembrane protein 127 | Dažnai (30–79%) | 1 ligoje |
| TPM2tropomyosin 2 | Dažnai (30–79%) | 1 ligoje |
| TPM3tropomyosin 3 | Dažnai (30–79%) | 1 ligoje |
| TRAPPC11trafficking protein particle complex subunit 11 | Dažnai (30–79%) | 1 ligoje |
| TREM2triggering receptor expressed on myeloid cells 2 | Dažnai (30–79%) | 1 ligoje |
| TTRtransthyretin | Dažnai (30–79%) | 1 ligoje |
| TXNRD2thioredoxin reductase 2 | Dažnai (30–79%) | 1 ligoje |
| UBQLN2ubiquilin 2 | Dažnai (30–79%) | 1 ligoje |
| UNC13Aunc-13 homolog A | Dažnai (30–79%) | 1 ligoje |
| VAPBVAMP associated protein B and C | Dažnai (30–79%) | 1 ligoje |
| VCPvalosin containing protein | Dažnai (30–79%) | 1 ligoje |
| VHLvon Hippel-Lindau tumor suppressor | Dažnai (30–79%) | 2 ligose |
| WT1WT1 transcription factor | Dažnai (30–79%) | 2 ligose |
| ZBTB16zinc finger and BTB domain containing 16 | Dažnai (30–79%) | 1 ligoje |
| ZNRF3zinc and ring finger 3 | Dažnai (30–79%) | 1 ligoje |
| ACAT1acetyl-CoA acetyltransferase 1 | Kartais (5–29%) | 1 ligoje |
| AMNamnion associated transmembrane protein | Kartais (5–29%) | 1 ligoje |
| ANKRD55ankyrin repeat domain 55 | Kartais (5–29%) | 1 ligoje |
| BMP6bone morphogenetic protein 6 | Kartais (5–29%) | 1 ligoje |
| BRIP1BRCA1 interacting DNA helicase 1 | Kartais (5–29%) | 1 ligoje |
| BTKBruton tyrosine kinase | Kartais (5–29%) | 1 ligoje |
| CALRcalreticulin | Kartais (5–29%) | 1 ligoje |
| CCR1C-C motif chemokine receptor 1 | Kartais (5–29%) | 1 ligoje |
| CD247CD247 molecule | Kartais (5–29%) | 1 ligoje |
| COL4A5collagen type IV alpha 5 chain | Kartais (5–29%) | 1 ligoje |
| COL4A6collagen type IV alpha 6 chain | Kartais (5–29%) | 1 ligoje |
| CTR9CTR9 component of Paf1/RNA polymerase II complex | Kartais (5–29%) | 1 ligoje |
| CTRCchymotrypsin C | Kartais (5–29%) | 1 ligoje |
| CUBNcubilin | Kartais (5–29%) | 1 ligoje |
| DIS3L2DIS3 like 3'-5' exoribonuclease 2 | Kartais (5–29%) | 1 ligoje |
| DNAJC13DnaJ heat shock protein family (Hsp40) member C13 | Kartais (5–29%) | 1 ligoje |
| EIF4G1eukaryotic translation initiation factor 4 gamma 1 | Kartais (5–29%) | 1 ligoje |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Kartais (5–29%) | 1 ligoje |
| ERCC4ERCC excision repair 4, endonuclease catalytic subunit | Kartais (5–29%) | 1 ligoje |
| F5coagulation factor V | Kartais (5–29%) | 1 ligoje |
| FAAP100FA core complex associated protein 100 | Kartais (5–29%) | 1 ligoje |
| FANCAFA complementation group A | Kartais (5–29%) | 1 ligoje |
| FANCBFA complementation group B | Kartais (5–29%) | 1 ligoje |
| FANCCFA complementation group C | Kartais (5–29%) | 1 ligoje |
| FANCD2FA complementation group D2 | Kartais (5–29%) | 1 ligoje |
| FANCEFA complementation group E | Kartais (5–29%) | 1 ligoje |
| FANCFFA complementation group F | Kartais (5–29%) | 1 ligoje |
| FANCGFA complementation group G | Kartais (5–29%) | 1 ligoje |
| FANCIFA complementation group I | Kartais (5–29%) | 1 ligoje |
| FANCLFA complementation group L | Kartais (5–29%) | 1 ligoje |
| FANCMFA complementation group M | Kartais (5–29%) | 1 ligoje |
| FASFas cell surface death receptor | Kartais (5–29%) | 1 ligoje |
| FLI1Fli-1 proto-oncogene, ETS transcription factor | Kartais (5–29%) | 1 ligoje |
| GALCgalactosylceramidase | Kartais (5–29%) | 1 ligoje |
| GBA1glucosylceramidase beta 1 | Kartais (5–29%) | 1 ligoje |
| GIGYF2GRB10 interacting GYF protein 2 | Kartais (5–29%) | 1 ligoje |
| GNPTABN-acetylglucosamine-1-phosphate transferase subunits alpha and beta | Kartais (5–29%) | 1 ligoje |
| GPC3glypican 3 | Kartais (5–29%) | 1 ligoje |
| H19H19 imprinted maternally expressed transcript | Kartais (5–29%) | 1 ligoje |
| HFEhomeostatic iron regulator | Kartais (5–29%) | 1 ligoje |
| HMGCL3-hydroxy-3-methylglutaryl-CoA lyase | Kartais (5–29%) | 1 ligoje |
| IFIH1interferon induced with helicase C domain 1 | Kartais (5–29%) | 1 ligoje |
| IFNGR1interferon gamma receptor 1 | Kartais (5–29%) | 2 ligose |
| IL12Ainterleukin 12A | Kartais (5–29%) | 1 ligoje |
| IL12A-AS1IL12A antisense RNA 1 | Kartais (5–29%) | 1 ligoje |
| IL23Rinterleukin 23 receptor | Kartais (5–29%) | 1 ligoje |
| IL2RAinterleukin 2 receptor subunit alpha | Kartais (5–29%) | 1 ligoje |
| IL2RBinterleukin 2 receptor subunit beta | Kartais (5–29%) | 1 ligoje |
| IVDisovaleryl-CoA dehydrogenase | Kartais (5–29%) | 1 ligoje |
| JPH3junctophilin 3 | Kartais (5–29%) | 2 ligose |
| KLRC4killer cell lectin like receptor C4 | Kartais (5–29%) | 1 ligoje |
| LRRK2leucine rich repeat kinase 2 | Kartais (5–29%) | 1 ligoje |
| MAD2L2mitotic arrest deficient 2 like 2 | Kartais (5–29%) | 1 ligoje |
| MAP2K1mitogen-activated protein kinase kinase 1 | Kartais (5–29%) | 1 ligoje |
| MEFVMEFV innate immunity regulator, pyrin | Kartais (5–29%) | 1 ligoje |
| MPLMPL proto-oncogene, thrombopoietin receptor | Kartais (5–29%) | 1 ligoje |
| NAB2NGFI-A binding protein 2 | Kartais (5–29%) | 1 ligoje |
| NR0B1nuclear receptor subfamily 0 group B member 1 | Kartais (5–29%) | 1 ligoje |
| NRASNRAS proto-oncogene, GTPase | Kartais (5–29%) | 1 ligoje |
| PANK2pantothenate kinase 2 | Kartais (5–29%) | 1 ligoje |
| PKHD1PKHD1 ciliary IPT domain containing fibrocystin/polyductin | Kartais (5–29%) | 1 ligoje |
| POU6F2POU class 6 homeobox 2 | Kartais (5–29%) | 1 ligoje |
| PRNPprion protein (Kanno blood group) | Kartais (5–29%) | 4 ligose |
| PSAPprosaposin | Kartais (5–29%) | 1 ligoje |
| PTPN2protein tyrosine phosphatase non-receptor type 2 | Kartais (5–29%) | 1 ligoje |
| RAD51RAD51 recombinase | Kartais (5–29%) | 1 ligoje |
| RAD51CRAD51 paralog C | Kartais (5–29%) | 1 ligoje |
| RESTRE1 silencing transcription factor | Kartais (5–29%) | 1 ligoje |
| RFWD3ring finger and WD repeat domain 3 | Kartais (5–29%) | 1 ligoje |
| RNF168ring finger protein 168 | Kartais (5–29%) | 1 ligoje |
| RNU7-1RNA, U7 small nuclear 1 | Kartais (5–29%) | 1 ligoje |
| SCNN1Asodium channel epithelial 1 subunit alpha | Kartais (5–29%) | 1 ligoje |
| SCNN1Bsodium channel epithelial 1 subunit beta | Kartais (5–29%) | 1 ligoje |
| SCNN1Gsodium channel epithelial 1 subunit gamma | Kartais (5–29%) | 1 ligoje |
| SLC34A2solute carrier family 34 member 2 | Kartais (5–29%) | 1 ligoje |
| SLC39A4solute carrier family 39 member 4 | Kartais (5–29%) | 1 ligoje |
| SLX4SLX4 structure-specific endonuclease subunit | Kartais (5–29%) | 1 ligoje |
| SNCAsynuclein alpha | Kartais (5–29%) | 2 ligose |
| SPINK1serine peptidase inhibitor Kazal type 1 | Kartais (5–29%) | 1 ligoje |
| STAT6signal transducer and activator of transcription 6 | Kartais (5–29%) | 1 ligoje |
| THPOthrombopoietin | Kartais (5–29%) | 1 ligoje |
| TLR4toll like receptor 4 | Kartais (5–29%) | 1 ligoje |
| TRIM28tripartite motif containing 28 | Kartais (5–29%) | 1 ligoje |
| TRIP13thyroid hormone receptor interactor 13 | Kartais (5–29%) | 1 ligoje |
| TWNKtwinkle mtDNA helicase | Kartais (5–29%) | 1 ligoje |
| UBAC2UBA domain containing 2 | Kartais (5–29%) | 1 ligoje |
| UBE2Tubiquitin conjugating enzyme E2 T | Kartais (5–29%) | 1 ligoje |
| UNC45Aunc-45 myosin chaperone A | Kartais (5–29%) | 1 ligoje |
| VPS13Avacuolar protein sorting 13 homolog A | Kartais (5–29%) | 1 ligoje |
| VPS35VPS35 retromer complex component | Kartais (5–29%) | 1 ligoje |
| XRCC2X-ray repair cross complementing 2 | Kartais (5–29%) | 1 ligoje |
| CD28CD28 molecule | Retai (1–4 %) | 1 ligoje |
| RB1RB transcriptional corepressor 1 | Retai (1–4 %) | 1 ligoje |
| TNFRSF1BTNF receptor superfamily member 1B | Retai (1–4 %) | 1 ligoje |
| CD244CD244 molecule | Neužfiksuota | 1 ligoje |
| CIITAclass II major histocompatibility complex transactivator | Neužfiksuota | 1 ligoje |
| CYP24A1cytochrome P450 family 24 subfamily A member 1 | Neužfiksuota | 1 ligoje |
| IL6interleukin 6 | Neužfiksuota | 1 ligoje |
| NFKBIL1NFKB inhibitor like 1 | Neužfiksuota | 1 ligoje |
| SLC22A4solute carrier family 22 member 4 | Neužfiksuota | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Siauresni požymiai
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.17-8666dff2.
AtlasKam padedameMūsų mokslasProduktaiRezultatai
PrisijungtiKlaustiSekvenuokite savo genomą↗
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites